MMP2 and neoplasm: It has been shown to enhance tumor cell migration by increasing MMP-2 expression, to inhibit antitumor immunity by blocking the response of immune cells to IL-12, and to act antiapoptotically by inducing or inhibiting different signaling pathways [29–31].